Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in JAMA Network Open.

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

Protection against RSV among infants and birthing parents differed by race and ethnicity, indicating the need to ensure equitable access to RSV products.

An infectious disease expert reveals there's one free thing everyone can do to help prevent getting a cold this winter. Read ...

The Allan Labor Government is backing a new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation ...

Some assume pneumonia is an inevitable consequence of ageing, while others may not realise they are at risk, says infectious ...